Noninvasive Brain Stimulation in Primary Progressive Aphasia with and Without Concomitant Speech and Language Therapy: Systematic Review and Meta-analysis.
Francesco Lomi, Ilaria Simonelli, Stefano Cappa, Patrizio Pasqualetti, Simone Rossi
{"title":"Noninvasive Brain Stimulation in Primary Progressive Aphasia with and Without Concomitant Speech and Language Therapy: Systematic Review and Meta-analysis.","authors":"Francesco Lomi, Ilaria Simonelli, Stefano Cappa, Patrizio Pasqualetti, Simone Rossi","doi":"10.1007/s11065-025-09659-5","DOIUrl":null,"url":null,"abstract":"<p><p>Primary progressive aphasias (PPA) represent a group of neurodegenerative conditions affecting verbal communication abilities for which no effective medication is currently available. Noninvasive brain stimulation (NiBS) has been mainly explored as adjunctive therapy to conventional speech and language therapy (SLT) with promising results. The present meta-analysis of randomized-controlled trials (RCTs) aims to evaluate the efficacy of NiBS in PPA patients on a range of linguistic tasks (naming, phonemic fluency, semantic fluency). A literature search was carried out using EMBASE and PUBMED, searching for multi-session RCTs administering NiBS on PPA patients as stand-alone or with SLT. The results were not significant overall, indicating a null difference between the active and the sham condition on language functions; pooled effects tended to be higher in parallel than in crossover studies and for follow-ups than post-treatment. In the naming analyses, the combined effects for the studies that coupled NiBS with SLT were slightly higher than the overall effect at each time point, although not significant. These results need to be considered with caution given the low number of included studies and small sample sizes, but offer relevant indications for future research in terms of optimal treatment protocols and personalization of therapies.</p>","PeriodicalId":49754,"journal":{"name":"Neuropsychology Review","volume":" ","pages":""},"PeriodicalIF":5.4000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neuropsychology Review","FirstCategoryId":"102","ListUrlMain":"https://doi.org/10.1007/s11065-025-09659-5","RegionNum":2,"RegionCategory":"心理学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
引用次数: 0
Abstract
Primary progressive aphasias (PPA) represent a group of neurodegenerative conditions affecting verbal communication abilities for which no effective medication is currently available. Noninvasive brain stimulation (NiBS) has been mainly explored as adjunctive therapy to conventional speech and language therapy (SLT) with promising results. The present meta-analysis of randomized-controlled trials (RCTs) aims to evaluate the efficacy of NiBS in PPA patients on a range of linguistic tasks (naming, phonemic fluency, semantic fluency). A literature search was carried out using EMBASE and PUBMED, searching for multi-session RCTs administering NiBS on PPA patients as stand-alone or with SLT. The results were not significant overall, indicating a null difference between the active and the sham condition on language functions; pooled effects tended to be higher in parallel than in crossover studies and for follow-ups than post-treatment. In the naming analyses, the combined effects for the studies that coupled NiBS with SLT were slightly higher than the overall effect at each time point, although not significant. These results need to be considered with caution given the low number of included studies and small sample sizes, but offer relevant indications for future research in terms of optimal treatment protocols and personalization of therapies.
期刊介绍:
Neuropsychology Review is a quarterly, refereed publication devoted to integrative review papers on substantive content areas in neuropsychology, with particular focus on populations with endogenous or acquired conditions affecting brain and function and on translational research providing a mechanistic understanding of clinical problems. Publication of new data is not the purview of the journal. Articles are written by international specialists in the field, discussing such complex issues as distinctive functional features of central nervous system disease and injury; challenges in early diagnosis; the impact of genes and environment on function; risk factors for functional impairment; treatment efficacy of neuropsychological rehabilitation; the role of neuroimaging, neuroelectrophysiology, and other neurometric modalities in explicating function; clinical trial design; neuropsychological function and its substrates characteristic of normal development and aging; and neuropsychological dysfunction and its substrates in neurological, psychiatric, and medical conditions. The journal''s broad perspective is supported by an outstanding, multidisciplinary editorial review board guided by the aim to provide students and professionals, clinicians and researchers with scholarly articles that critically and objectively summarize and synthesize the strengths and weaknesses in the literature and propose novel hypotheses, methods of analysis, and links to other fields.